Compounds > piperacillin
Page last updated: 2024-08-23

piperacillin and B cepacia Infection

piperacillin has been researched along with B cepacia Infection in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's4 (66.67)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alba, L; Chen, Y; Garber, E; Saiman, L; Tabibi, S; Zhou, J1
Barnes, MD; Becka, SA; LiPuma, JJ; Papp-Wallace, KM; Wilson, BM; Zeiser, ET1
Belli, ML; Cruciani, M; Fenu, ML; Manno, G; Romano, L; Ugolotti, E1
Chan, KW; Chan, TM; Lai, KN; Li, FK1
Cipriani, P; Nicoletti, M; Petrucca, A; Pustorino, R; Santapaola, D; Sessa, R; Teggi, A1
Bingen, E; Bonacorsi, S; Fitoussi, F; Lhopital, S1

Other Studies

6 other study(ies) available for piperacillin and B cepacia Infection

ArticleYear
Antimicrobial susceptibility and synergy studies of Burkholderia cepacia complex isolated from patients with cystic fibrosis.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:3

    Topics: Anti-Bacterial Agents; Burkholderia cepacia complex; Burkholderia Infections; Cystic Fibrosis; Drug Resistance, Multiple, Bacterial; Drug Synergism; Humans; Microbial Sensitivity Tests

2007
"Switching Partners": Piperacillin-Avibactam Is a Highly Potent Combination against Multidrug-Resistant
    Journal of clinical microbiology, 2019, Volume: 57, Issue:8

    Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Burkholderia cepacia complex; Burkholderia gladioli; Burkholderia Infections; Cystic Fibrosis; Drug Resistance, Multiple, Bacterial; Drug Substitution; Humans; Kinetics; Microbial Sensitivity Tests; Piperacillin

2019
Use of the E test to assess synergy of antibiotic combinations against isolates of Burkholderia cepacia-complex from patients with cystic fibrosis.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2003, Volume: 22, Issue:1

    Topics: Bacteriological Techniques; Burkholderia cepacia; Burkholderia Infections; Ceftazidime; Chi-Square Distribution; Child; Child, Preschool; Ciprofloxacin; Cystic Fibrosis; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Female; Humans; Lactams; Male; Microbial Sensitivity Tests; Piperacillin; Rifampin; Sensitivity and Specificity

2003
Burkholderia urinary tract infection after renal transplantation.
    Transplant infectious disease : an official journal of the Transplantation Society, 2003, Volume: 5, Issue:1

    Topics: Burkholderia cepacia; Burkholderia Infections; Humans; Kidney Transplantation; Male; Middle Aged; Piperacillin; Urinary Tract Infections

2003
Burkholderia cenocepacia vaginal infection in patient with smoldering myeloma and chronic hepatitis C.
    Emerging infectious diseases, 2004, Volume: 10, Issue:11

    Topics: Aged; Anti-Bacterial Agents; Burkholderia cepacia complex; Burkholderia Infections; Drug Resistance, Multiple, Bacterial; Female; Hepatitis C, Chronic; Humans; Multiple Myeloma; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Vaginosis, Bacterial

2004
Comparative in vitro activities of meropenem, imipenem, temocillin, piperacillin, and ceftazidime in combination with tobramycin, rifampin, or ciprofloxacin against Burkholderia cepacia isolates from patients with cystic fibrosis.
    Antimicrobial agents and chemotherapy, 1999, Volume: 43, Issue:2

    Topics: Burkholderia cepacia; Burkholderia Infections; Ceftazidime; Ciprofloxacin; Cystic Fibrosis; Drug Synergism; Drug Therapy, Combination; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Penicillins; Piperacillin; Rifampin; Thienamycins; Tobramycin

1999